Eclipse Therapeutics, Inc is categorized under Research and Development Laboratories in San Diego, CA and active since 2010.
Eclipse Therapeutics, Inc was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number by the NAICS.
If you are seeking more information, feel free to contact Peter Chu at the company’s single location by writing to Sorrento Valley, San Diego, California CA 92130 or by phoning (858) 793-1487. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Eclipse Therapeutics, Inc |
| Contact Person: | Peter Chu |
| Address: | Sorrento Valley, San Diego, California 92130 |
| Phone Number: | (858) 793-1487 |
| Website Address: | eclipsetherapeutics.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| Share This Business: |
Eclipse Therapeutics, Inc was started in 2010 to provide professional Research and Development Laboratories under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Peter Chu for inquiries that concern Eclipse Therapeutics, Inc by calling the company number (858) 793-1487, as your correspondence is most welcome. Additionally, the physical location of the single location of Eclipse Therapeutics, Inc can be found at the coordinates 32.913193,-117.231071 as well as the street address Sorrento Valley in San Diego, California 92130.
For its online presence, you may visit Eclipse Therapeutics, Inc’s website at eclipsetherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.